References
- Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-217. https://doi.org/10.1038/nature03342
- Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002; 415: 670-672. https://doi.org/10.1038/415670a
- Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW. The global distribution and population at risk of malaria: Past, present, and future. Lancet Infect Dis 2004; 4: 327-336. https://doi.org/10.1016/S1473-3099(04)01043-6
- Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64(1-2 suppl): 97-106. https://doi.org/10.4269/ajtmh.2001.64.97
- Edrissian GH. Malaria in Iran: past and present situation. Iranian J Parasitol 2006; 1: 1-14.
- Soler E, Houdebine LM. Preparation of recombinant vaccines. Biotechnol Annu Rev 2007; 13: 65-94.
- Giraldo MA, Arevalo-Pinzon G, Rojas-Caraballo J, Mongui A, Rodriguez R, Patarroyo MA. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection. Vaccine 2009; 28: 7-13. https://doi.org/10.1016/j.vaccine.2009.09.046
- Voller A, Meuwissen JHE, Verhave H. Methods of measuring the immunological response to Plasmodia. In Kreier JP eds, Immunology and Immunisation. Malaria. Vol. 3. New York, USA. Academic Press. 1980, p 67-109.
- Voller A, Huldt G, Thors C, Engvall E. New serological test for malaria antibodies. Br Med J 1975; 1: 659-661. https://doi.org/10.1136/bmj.1.5959.659
- Rodrigues MH, Rodrigues KM, Oliveira TR, Comodo AN, Rodrigues MM, Kocken CH, Thomas AW, Soares IS. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1. Int J Parasitol 2005; 35: 185-192. https://doi.org/10.1016/j.ijpara.2004.11.003
- Serological testing in malaria. Bull World Health Organ 1974; 50: 527-35.
- Altman DG. Practical statistics for medical research. London, UK. Chapman & Hall. 2001.
- Babakhan L, Mohebali M, Akhoundi B, Edrissian GH, Keshavarz H. Rapid detection of Leishmania infantum infection in dogs: A comparative study using fast agglutination screening test (FAST) and direct agglutination test (DAT) in Iran. Parasitol Res 2009; 105: 717-720. https://doi.org/10.1007/s00436-009-1456-3
- James S, Miller L. Malaria vaccine development: Status report. Nature Med Suppl 2000.
- Vekemans J, Ballou WR. Plasmodium falciparum malaria vaccines in development. Expert Rev Vaccines 2008; 7: 223-240. https://doi.org/10.1586/14760584.7.2.223
- Morais CG, Soares IS, Carvalho LH, Fontes CJ, Krettli AU, Braga EM. Antibodies to Plasmodium vivax apical membrane antigen 1: Persistence and correlation with malaria transmission intensity. Am J Trop Med Hyg 2006; 75: 582-587.
- Mahanty S, Saul A, Miller LH. Progress in the development of recombinant and synthetic blood-stage malaria vaccines. J Exp Biol 2003; 206(Pt 21): 3781-3788. https://doi.org/10.1242/jeb.00646
- Herrera S, Corradin G, Arevalo-Herrera M. An update on the search for a Plasmodium vivax vaccine. Trends Parasitol 2007; 23: 122-128. https://doi.org/10.1016/j.pt.2007.01.008
- Bueno LL, Morais CG, Soares IS, Bouillet LE, Bruna-Romero O, Fontes CJ, Fujiwara RT, Braga EM. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells. Vaccine 2009; 27: 5581-5588. https://doi.org/10.1016/j.vaccine.2009.07.031
- Remarque EJ, Faber BW, Kocken CH, Thomas AW. Apical mem brane antigen 1: A malaria vaccine candidate in review. Trends Parasitol 2008; 24: 74-84. https://doi.org/10.1016/j.pt.2007.12.002
- Thomas AW, Deans JA, Mitchell GH, Alderson T, Cohen S. The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit Plasmodium knowlesi invasion of erythrocytes. Mol Biochem Parasitol 1984; 13: 187-199. https://doi.org/10.1016/0166-6851(84)90112-9
- Deans JA, Alderson T, Thomas AW, Mitchell GH, Lennox ES, Cohen S. Rat monoclonal antibodies which inhibit the in vitro multiplication of Plasmodium knowlesi. Clin Exp Immunol 1982; 49: 297-309.
- Wickramarachchi T, Premaratne PH, Perera KL, Bandara S, Kocken CH, Thomas AW, Handunnetti SM, Udagama-Randeniya PV. Natural human antibody responses to Plasmodium vivax apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka. Infect Immun 2006; 74: 798-801. https://doi.org/10.1128/IAI.74.1.798-801.2006
- Kim S, Ahn HJ, Kim TS, Nam HW. ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas. Korean J Parasitol 2003; 41: 203-207. https://doi.org/10.3347/kjp.2003.41.4.203
- Mehrizi AA, Zakeri S, Salmanian AH, Sanati MH, Djadid ND. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran. Acta Trop 2009; 112: 1-7. https://doi.org/10.1016/j.actatropica.2009.05.016
- Thomas AW, Trape JF, Rogier C, Goncalves A, Rosario VE, Narum DL. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1. Am J Trop Med Hyg 1994; 51: 730-740. https://doi.org/10.4269/ajtmh.1994.51.730
- Nair M, Hinds MG, Coley AM, Hodder AN, Foley M, Anders RF, Norton RS. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). J Mol Biol 2002; 322: 741-753. https://doi.org/10.1016/S0022-2836(02)00806-9
- Holder AA. Preventing merozoite invasion of erythrocytes. In: Hoffman SL, ed, Malaria vaccine development: A multi-immune response approach. Washington DC, USA. American Society of Microbiology. 1996, p 77-104.
- Krotoski WA. Discovery of the hypnozoite and a new theory of malarial relapse. Trans R Soc Trop Med Hyg 1985; 79: 1-11. https://doi.org/10.1016/0035-9203(85)90221-4
Cited by
- Immunogenicity of bacterial-expressed recombinant Plasmodium knowlesi merozoite surface protein-1 42 (MSP-1 42 ) vol.12, pp.None, 2013, https://doi.org/10.1186/1475-2875-12-454
- Evaluation of Recombinant Plasmodium knowlesi Merozoite Surface Protein-133 for Detection of Human Malaria vol.88, pp.5, 2012, https://doi.org/10.4269/ajtmh.12-0250
- What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates? vol.8, pp.None, 2012, https://doi.org/10.3389/fimmu.2017.00126
- Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: A nine year follow-up study in the Amazon region vol.13, pp.11, 2012, https://doi.org/10.1371/journal.pone.0207244
- The immunology of Plasmodium vivax malaria vol.293, pp.1, 2020, https://doi.org/10.1111/imr.12816
- Structure-genetic diversity and recombinant protein of circumsporozoite protein (CSP) of vivax malaria antigen: A potential malaria vaccine candidate vol.23, pp.None, 2012, https://doi.org/10.1016/j.genrep.2021.101132